Genome-wide analysis of prostate cancer risk SNPs and somatic SNVs demonstrated that they converge and enrich at the binding sites of other master transcription factors besides FOXA1, including AR, HOXB13 and SOX9 (Ahmed et al. 2017; Mazrooei et al. 2019). The gene discussed is FOXA1; the disease is prostate carcinoma.